Medical resource utilization analysis showed that medical resource use for XELODA was reduced as compared to intravenous 5-FU/LV.

• 医疗资源使用分析显示希罗达的医疗资源使用与静脉推注5-FU/LV在治疗结肠癌患者相比是有所降低的。